Literature DB >> 21857469

Prospects of robotic thyroidectomy using a gasless, transaxillary approach for the management of thyroid carcinoma.

Sang-Wook Kang1, Jae Hyun Park, Jun Soo Jeong, Cho Rok Lee, Seulkee Park, So Hee Lee, Jong Ju Jeong, Kee-Hyun Nam, Woong Youn Chung, Cheong Soo Park.   

Abstract

PURPOSE: Robotic surgical systems are among the most innovative surgical developments and have radically promoted the use of minimally invasive techniques. Robotic technologies using different approaches have also been applied to thyroid surgery. Recently, the authors described a novel robotic surgical method for thyroid surgery based on a gasless, transaxillary approach (TAA), and have since serially reported on its technical feasibility and safety. Here, the authors report their experience of a consecutive series of 1000 cases treated using robotic thyroidectomy, and demonstrate its use for the surgical management of thyroid cancer. PATIENTS AND METHODS: From October 2007 to November 2009, 1000 patients with thyroid cancer underwent robot-assisted endoscopic thyroid surgery using a gasless TAA. All patients were selected using predetermined inclusion criteria after considering surgical risk, and all procedures were completed successfully using the da Vinci S or Si surgical system (Intuitive Surgical, Sunnyvale, CA). Patient's clinicopathologic characteristics, operation types, operation times, numbers of retrieved lymph nodes (LNs), postoperative hospital stays, complications, and short-term follow-up results were analyzed.
RESULTS: Mean patient age was 39.1 ± 9.6 years and the male-to-female ratio was 1:12.6 (73:927). Six hundred twenty-seven patients underwent less than total and 373 patients underwent bilateral total thyroidectomy. Ipsilateral central compartment node dissection was conducted in all 1000 cases and additional lateral neck node dissection was conducted in 36 of the 1000 patients. Mean operation time was 136.7 ± 44.4 minutes and mean postoperative hospital stay was 3.0 ± 0.45 days. No serious postoperative complication occurred, except 3 cases of recurrent laryngeal nerve injury, and 1 case of Horner syndrome. Mean tumor size was 0.79 ± 0.6 cm and papillary thyroid microcarcinoma was in 752 cases (75.5%). The mean number of retrieved central LNs per patient was 4.62 ± 3.14. Central neck LN metastasis occurred in 361(36.1%) and lateral neck LN metastasis in 36 cases (3.6%). According to tumor nodes metastasis staging, 847 patients (84.7%) were of stage I, 144 patients (14.4%) were of stage III, and 9 patients (0.9%) were of stage IVA.
CONCLUSIONS: The authors conclude that robotic thyroidectomy using a gasless TAA is a feasible, safe, and promising surgical alternative for selected patients with low-risk thyroid cancer, and recommend that the inclusion criteria of this technique be gradually extended to advanced thyroid cancer given suitable operator experience and future developments in robotic systems and instrumentation.

Entities:  

Mesh:

Year:  2011        PMID: 21857469     DOI: 10.1097/SLE.0b013e3182266f31

Source DB:  PubMed          Journal:  Surg Laparosc Endosc Percutan Tech        ISSN: 1530-4515            Impact factor:   1.719


  32 in total

1.  Gasless transaxillary robotic versus endoscopic thyroidectomy: exploring the frontiers of scarless thyroidectomy through a preliminary comparison study.

Authors:  Andreas Kiriakopoulos; Dimitrios Linos
Journal:  Surg Endosc       Date:  2012-04-27       Impact factor: 4.584

2.  A prospective 1-year comparative study of transaxillary total thyroidectomy regarding functional outcomes: Is it really promising?

Authors:  Doh Young Lee; Saehee Lim; Sung Hoon Kang; Kyoung Ho Oh; Jae-Gu Cho; Seung-Kuk Baek; Jeong-Soo Woo; Soon-Young Kwon; Kwang-Yoon Jung
Journal:  Surg Endosc       Date:  2015-07-21       Impact factor: 4.584

3.  "Scarless" (in the neck) endoscopic thyroidectomy (SET) with ipsilateral levels II, III, and IV dissection via breast approach for papillary thyroid carcinoma: a preliminary report.

Authors:  Haichao Yan; Yong Wang; Ping Wang; Qiuping Xie; Qunzi Zhao
Journal:  Surg Endosc       Date:  2014-11-27       Impact factor: 4.584

4.  Indications for the gasless transaxillary robotic approach to thyroid surgery: experience of forty-seven procedures at the american hospital of paris.

Authors:  Patrick Aidan; Helen Pickburn; Hervé Monpeyssen; Gilles Boccara
Journal:  Eur Thyroid J       Date:  2013-06-14

5.  Robot-assisted transaxillary thyroid surgery: as safe as conventional-access thyroid surgery?

Authors:  Henning Dralle
Journal:  Eur Thyroid J       Date:  2013-06

6.  Neck dissection through a facelift incision.

Authors:  Thuy-Anh N Melvin; Steven J Eliades; Patrick K Ha; Carole Fakhry; John M Saunders; Joseph A Califano; Ray G F Blanco
Journal:  Laryngoscope       Date:  2012-09-28       Impact factor: 3.325

7.  Preoperative scar perception study comparing 'scarless' in the neck endoscopic thyroidectomy with open thyroidectomy: a cross-sectional study.

Authors:  T Y Qiu; Jwl Lau; O Wong; H B Oh; T W Boon; R Parameswaran; K Y Ngiam
Journal:  Ann R Coll Surg Engl       Date:  2020-08-21       Impact factor: 1.891

8.  Yonsei Experience of 5000 Gasless Transaxillary Robotic Thyroidectomies.

Authors:  Min Jhi Kim; Kee-Hyun Nam; Seul Gi Lee; Jung Bum Choi; Tae Hyung Kim; Cho Rok Lee; Jandee Lee; Sang-Wook Kang; Jong Ju Jeong; Woong Youn Chung
Journal:  World J Surg       Date:  2018-02       Impact factor: 3.352

9.  Transaxillary robotic modified radical neck dissection: a 5-year assessment of operative and oncologic outcomes.

Authors:  Min Jhi Kim; Jandee Lee; Seul Gi Lee; Jung Bum Choi; Tae Hyung Kim; Eun Jeong Ban; Cho Rok Lee; Sang-Wook Kang; Jong Ju Jeong; Kee-Hyun Nam; Young Suk Jo; Woong Youn Chung
Journal:  Surg Endosc       Date:  2016-08-29       Impact factor: 4.584

10.  Robotic thyroidectomy for cancer in the US: patterns of use and short-term outcomes.

Authors:  Mohamed Abdelgadir Adam; Paul Speicher; John Pura; Michaela A Dinan; Shelby D Reed; Sanziana A Roman; Julie A Sosa
Journal:  Ann Surg Oncol       Date:  2014-06-17       Impact factor: 5.344

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.